Gilead Sciences Partners with LEO Pharma
This is a news story, published by Yahoo Finance, that relates primarily to Gilead news.
drug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
topical STAT6 products. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest LEO Pharma news, Gilead news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Gilead SciencesReuters
•Gilead, LEO Pharma partner to develop programs for inflammatory diseases
81% Informative
Danish company will be eligible to receive up to $1.7 billion in payments which include an upfront payment of $250 million from Gilead .
LEO Pharma may receive tiered royalties ranging from high single-digit to mid-teens on sales of topical STAT6 products.
VR Score
91
Informative language
96
Neutral language
79
Article tone
formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links